Elkem Crescita futura
Criteri Future verificati 4/6
Elkem prevede che gli utili e i ricavi cresceranno rispettivamente di 52.6% e 7.2% all'anno. Si prevede che l'EPS crescerà di 63.3% all'anno. Si prevede che il ritorno sul capitale proprio sarà di 9.7% in 3 anni.
Informazioni chiave
52.6%
Tasso di crescita degli utili
63.34%
Tasso di crescita dell'EPS
| Chemicals crescita degli utili | -3.2% |
| Tasso di crescita dei ricavi | 7.2% |
| Rendimento futuro del capitale proprio | 9.67% |
| Copertura analitica | Low |
| Ultimo aggiornamento | 11 May 2026 |
Aggiornamenti recenti sulla crescita futura
Recent updates
Aggiornamento della narrazione • May 15
ELK: Equity Raise And Biocarbon Project Will Support Future Upside
Elkem's updated analyst price target has shifted from NOK 33.29 to NOK 31.34, reflecting analysts' refreshed assumptions around revenue growth, profit margins, the discount rate, and future P/E expectations. What's in the News Elkem has filed a follow on equity offering of NOK 299.999997 million, offering 11,111,111 ordinary shares at NOK 27 per share through a rights offering (Key Developments).Aggiornamento della narrazione • Apr 25
ELK: New Three Division Structure And Workforce Cuts Will Support Upside
Analysts have made a small upward revision to Elkem's price target, moving it from NOK 33.14 to NOK 33.29. This reflects updated assumptions around revenue growth, profit margins and future P/E expectations.Aggiornamento della narrazione • Apr 10
ELK: New Three Division Structure And Cost Cuts Will Drive Upside
The analyst price target for Elkem has moved slightly higher to NOK33.14 from NOK32.83, with analysts citing adjustments in the assumed discount rate, revenue growth, profit margin, and future P/E to support the change. What's in the News Elkem is introducing a new corporate structure with three divisions: Elkem Silicon, Elkem Foundry Alloys and Elkem Carbon.Aggiornamento della narrazione • Mar 24
ELK: New Structure And Cost Cuts Will Support Future Upside
Analysts have kept their Elkem price target steady at NOK 32.83. They cite essentially unchanged assumptions for the discount rate, revenue growth, profit margin and future P/E as the basis for reaffirming their view.Aggiornamento della narrazione • Mar 10
ELK: Safety Actions And Stable Earnings Assumptions Will Support Upside Potential
Analysts have kept their fair value estimate for Elkem unchanged at NOK 32.83, with only small tweaks to assumptions on discount rate, revenue growth, profit margin and future P/E, which feed into an updated price target narrative. What's in the News An extraordinary general meeting on 9 March 2026 approved an amendment to Section 4 of Elkem ASA's articles of association, confirming share capital at NOK 1,505,514,210 divided into 301,102,842 shares with a nominal value of NOK 5 each (Key Developments).Aggiornamento della narrazione • Feb 23
ELK: Safety Actions And Earnings Assumptions Will Shape A Balanced Outlook
The analyst price target for Elkem has been adjusted from NOK 31.85 to NOK 32.83. Analysts cite updated assumptions across the discount rate, revenue growth, profit margin and forward P/E as the key drivers behind this change.Aggiornamento della narrazione • Feb 09
ELK: Safety Reforms After Saint Fons Incident Will Support Upbeat Outlook
Narrative Update on Elkem Analysts have kept their fair value estimate for Elkem steady at NOK 31.85. They explain the unchanged price target by slightly adjusting their assumptions for discount rate, revenue growth, profit margin and future P/E expectations, rather than changing their overall view of the company’s valuation.Aggiornamento della narrazione • Jan 25
ELK: Safety Incident And Minor Assumption Shifts Will Shape Balanced Outlook
Analysts have raised their fair value estimate for Elkem to €31.85 from €31.80, citing small adjustments to the discount rate, revenue growth, profit margin and forward P/E assumptions. What's in the News On 22 December 2025, an explosion occurred at a pilot workshop at the Elkem Silicones site in Saint Fons, Lyon, France, resulting in one employee losing his life and three others being injured (company report).Aggiornamento della narrazione • Jan 10
ELK: Medical Materials Push And Ferrosilicon Cuts Will Shape Balanced Outlook
Analysts now estimate Elkem's fair value at €31.80 per share, slightly higher than the previous estimate of €31.00, citing small adjustments to their discount rate, revenue growth, profit margin and future P/E assumptions. What's in the News Explosion at Elkem's Saint Fons silicones pilot workshop in Lyon on 22 December 2025 resulted in one fatality and three injuries, with management cooperating with local authorities and providing psychological support to employees (Key Developments).Aggiornamento della narrazione • Dec 25
ELK: Medical Materials Expansion And Ferrosilicon Curtailments Will Shape Measured Outlook
Analysts have raised their price target on Elkem to NOK 31.00 from NOK 29.80, reflecting updated assumptions of a slightly lower discount rate but higher future earnings multiples, despite somewhat softer expectations for revenue growth and profit margins. What's in the News Elkem ASA launched SILBIONE LSR Select EC 70, a next generation medical grade liquid silicone rubber engineered for wearable and diagnostic devices, combining high electrical conductivity, certified biocompatibility and enhanced process control (company announcement).Aggiornamento della narrazione • Dec 11
ELK: Medical Materials Expansion And Production Cuts Will Shape Balanced Outlook
Analysts have modestly raised their price target on Elkem to NOK 29.80, citing slightly lower perceived risk reflected in a reduced discount rate, while keeping growth, margin, and valuation assumptions broadly unchanged. What's in the News Elkem launched SILBIONE LSR Select EC 70, a next generation medical grade liquid silicone rubber designed for wearable and diagnostic devices, featuring high electrical conductivity, certified biocompatibility, and enhanced process control for precision healthcare applications (Key Developments).Aggiornamento della narrazione • Nov 27
ELK: New Medical-Grade Product Launch and Market Risks Will Shape Outlook
Analysts have maintained Elkem's fair value price target at NOK 29.80, citing stable underlying financial metrics and a slightly reduced discount rate as the basis for their decision. What's in the News Elkem ASA launched SILBIONE LSR Select EC 70, a next-generation medical-grade liquid silicone rubber designed for wearable and diagnostic devices.Aggiornamento della narrazione • Nov 13
ELK: Upcoming Medical Material Launch Will Support Increased Market Confidence
Narrative Update on Elkem: Analyst Price Target Revision Analysts have maintained their fair value estimate for Elkem at NOK 29.80. This reflects steady confidence in the company despite minor adjustments to key assumptions such as profit margin and growth projections.Aggiornamento della narrazione • Oct 29
Medical-Grade Silicone Launch and Production Cuts Will Balance Future Prospects
Analysts have raised their price target for Elkem from NOK 29.32 to NOK 29.80. This change reflects minor adjustments to their expectations for growth, discount rates, and profit margins.Aggiornamento della narrazione • Oct 15
Silicones Review And Carbon Capture R&D Will Improve Competitiveness
Elkem's analyst consensus price target has been raised from $27.92 to $29.32, reflecting analysts' expectations of slightly improved revenue growth and a lower discount rate that drives upward fair value adjustments. Valuation Changes The consensus analyst price target has increased from NOK 27.92 to NOK 29.32.Aggiornamento della narrazione • Sep 25
Silicones Review And Carbon Capture R&D Will Improve Competitiveness
Elkem's slight improvement in net profit margin has supported an upward revision of the consensus analyst price target from NOK26.40 to NOK27.92. What's in the News Elkem and NTE signed a long-term power purchase agreement for 300 GWh/year renewable power delivery (2028-2037) in Norway’s NO4 area.Articolo di analisi • Sep 20
Earnings Tell The Story For Elkem ASA (OB:ELK)
With a price-to-earnings (or "P/E") ratio of 23.4x Elkem ASA ( OB:ELK ) may be sending very bearish signals at the...Articolo di analisi • Jul 09
Is Now The Time To Look At Buying Elkem ASA (OB:ELK)?
While Elkem ASA ( OB:ELK ) might not have the largest market cap around , it received a lot of attention from a...Articolo di analisi • Jun 17
Does Elkem (OB:ELK) Have A Healthy Balance Sheet?
David Iben put it well when he said, 'Volatility is not a risk we care about. What we care about is avoiding the...Articolo di analisi • May 07
Shareholders Shouldn’t Be Too Comfortable With Elkem's (OB:ELK) Strong Earnings
Strong earnings weren't enough to please Elkem ASA's ( OB:ELK ) shareholders over the last week. We did some digging...Articolo di analisi • Apr 29
Elkem (OB:ELK) Will Want To Turn Around Its Return Trends
If we want to find a stock that could multiply over the long term, what are the underlying trends we should look for...Articolo di analisi • Mar 24
Is It Too Late To Consider Buying Elkem ASA (OB:ELK)?
Elkem ASA ( OB:ELK ), might not be a large cap stock, but it saw a significant share price rise of 36% in the past...
Nuova narrazione • Feb 09
Carbon Capture Initiatives Will Strengthen ESG Positioning And Brand Value
Expansion in China and targeted operational improvements aim to boost EBITDA, enhancing revenue and earnings growth.Articolo di analisi • Feb 05
Investors Still Aren't Entirely Convinced By Elkem ASA's (OB:ELK) Revenues Despite 26% Price Jump
The Elkem ASA ( OB:ELK ) share price has done very well over the last month, posting an excellent gain of 26%. While...Articolo di analisi • Jan 23
Here's Why Elkem (OB:ELK) Is Weighed Down By Its Debt Load
Warren Buffett famously said, 'Volatility is far from synonymous with risk.' It's only natural to consider a company's...Articolo di analisi • Dec 19
Market Still Lacking Some Conviction On Elkem ASA (OB:ELK)
You may think that with a price-to-sales (or "P/S") ratio of 0.3x Elkem ASA ( OB:ELK ) is definitely a stock worth...Articolo di analisi • Nov 02
There May Be Reason For Hope In Elkem's (OB:ELK) Disappointing Earnings
Soft earnings didn't appear to concern Elkem ASA's ( OB:ELK ) shareholders over the last week. Our analysis suggests...Articolo di analisi • Oct 27
Elkem ASA Just Missed EPS By 51%: Here's What Analysts Think Will Happen Next
It's shaping up to be a tough period for Elkem ASA ( OB:ELK ), which a week ago released some disappointing...Articolo di analisi • Sep 04
Little Excitement Around Elkem ASA's (OB:ELK) Revenues
You may think that with a price-to-sales (or "P/S") ratio of 0.4x Elkem ASA ( OB:ELK ) is definitely a stock worth...Articolo di analisi • Aug 07
The Returns On Capital At Elkem (OB:ELK) Don't Inspire Confidence
If you're looking for a multi-bagger, there's a few things to keep an eye out for. Ideally, a business will show two...Articolo di analisi • Jul 17
Elkem ASA Beat Analyst Estimates: See What The Consensus Is Forecasting For This Year
Elkem ASA ( OB:ELK ) investors will be delighted, with the company turning in some strong numbers with its latest...Articolo di analisi • Jun 11
These 4 Measures Indicate That Elkem (OB:ELK) Is Using Debt In A Risky Way
Some say volatility, rather than debt, is the best way to think about risk as an investor, but Warren Buffett famously...Articolo di analisi • May 27
Elkem ASA's (OB:ELK) Revenues Are Not Doing Enough For Some Investors
Elkem ASA's ( OB:ELK ) price-to-sales (or "P/S") ratio of 0.4x might make it look like a strong buy right now compared...Articolo di analisi • May 11
Elkem ASA's (OB:ELK) Intrinsic Value Is Potentially 24% Below Its Share Price
Key Insights The projected fair value for Elkem is kr15.80 based on 2 Stage Free Cash Flow to Equity Current share...Articolo di analisi • Apr 22
Analysts Have Made A Financial Statement On Elkem ASA's (OB:ELK) First-Quarter Report
Elkem ASA ( OB:ELK ) just released its latest first-quarter report and things are not looking great. It was a pretty...Articolo di analisi • Apr 09
What Does Elkem ASA's (OB:ELK) Share Price Indicate?
Elkem ASA ( OB:ELK ), is not the largest company out there, but it saw a double-digit share price rise of over 10% in...Articolo di analisi • Dec 15
Is Elkem (OB:ELK) A Risky Investment?
The external fund manager backed by Berkshire Hathaway's Charlie Munger, Li Lu, makes no bones about it when he says...Articolo di analisi • Oct 23
Why Elkem ASA (OB:ELK) Could Be Worth Watching
Elkem ASA ( OB:ELK ), might not be a large cap stock, but it saw significant share price movement during recent months...Previsioni di crescita degli utili e dei ricavi
| Data | Ricavi | Utili | Flusso di cassa libero | Liquidità dell'operazione | Avg. Numero di analisti |
|---|---|---|---|---|---|
| 12/31/2028 | 19,409 | 1,613 | 873 | 2,579 | 4 |
| 12/31/2027 | 18,539 | 1,308 | 614 | 2,144 | 4 |
| 12/31/2026 | 16,310 | 544 | 1,307 | 2,439 | 4 |
| 3/31/2026 | 16,306 | 331 | -361 | 1,672 | N/A |
| 12/31/2025 | 16,535 | 301 | -1,183 | 1,176 | N/A |
| 9/30/2025 | 16,901 | 484 | -1,233 | 1,578 | N/A |
| 6/30/2025 | 16,980 | 699 | -1,243 | 1,702 | N/A |
| 3/31/2025 | 17,458 | 2,123 | -1,820 | 1,165 | N/A |
| 12/31/2024 | 17,810 | 2,026 | -1,368 | 2,030 | N/A |
| 9/30/2024 | 8,308 | 3,256 | -2,470 | 965 | N/A |
| 6/30/2024 | 11,900 | 2,367 | -2,320 | 1,953 | N/A |
| 3/31/2024 | 16,058 | 1,085 | -2,120 | 2,696 | N/A |
| 12/31/2023 | 21,134 | 1,999 | -2,219 | 2,769 | N/A |
| 9/30/2023 | 36,517 | 1,427 | -402 | 4,959 | N/A |
| 6/30/2023 | 39,820 | 4,929 | 1,126 | 6,081 | N/A |
| 3/31/2023 | 42,988 | 7,855 | 2,987 | 7,513 | N/A |
| 12/31/2022 | 45,017 | 9,561 | 5,101 | 9,314 | N/A |
| 9/30/2022 | 45,073 | 10,631 | 5,016 | 8,989 | N/A |
| 6/30/2022 | 42,671 | 8,956 | 4,308 | 8,191 | N/A |
| 3/31/2022 | 37,733 | 6,602 | 3,115 | 6,676 | N/A |
| 12/31/2021 | 33,083 | 4,628 | 1,647 | 4,913 | N/A |
| 9/30/2021 | 29,779 | 2,770 | 1,541 | 4,377 | N/A |
| 6/30/2021 | 26,856 | 1,294 | 800 | 3,068 | N/A |
| 3/31/2021 | 25,387 | 672 | -263 | 2,138 | N/A |
| 12/31/2020 | 24,025 | 239 | -235 | 2,111 | N/A |
| 9/30/2020 | 22,498 | 150 | -557 | 1,834 | N/A |
| 6/30/2020 | 22,260 | 460 | -583 | 2,028 | N/A |
| 3/31/2020 | 22,204 | 616 | 14 | 2,527 | N/A |
| 12/31/2019 | 22,245 | 855 | N/A | 1,839 | N/A |
| 9/30/2019 | 22,840 | 1,211 | N/A | 2,805 | N/A |
| 6/30/2019 | 23,138 | 1,921 | N/A | 3,178 | N/A |
| 3/31/2019 | 24,282 | 3,104 | N/A | 3,801 | N/A |
| 12/31/2018 | 24,968 | 3,337 | N/A | 4,460 | N/A |
| 9/30/2018 | 25,216 | 3,620 | N/A | 3,611 | N/A |
| 6/30/2018 | 24,680 | 3,077 | N/A | 3,583 | N/A |
| 3/31/2018 | 22,995 | 2,011 | N/A | 2,644 | N/A |
| 12/31/2017 | 21,133 | 1,211 | N/A | 2,256 | N/A |
| 12/31/2016 | 14,045 | 722 | N/A | 1,304 | N/A |
| 12/31/2015 | 14,361 | 809 | N/A | 1,820 | N/A |
Previsioni di crescita futura degli analisti
Guadagni vs tasso di risparmio: La crescita prevista degli utili di ELK ( 52.6% all'anno) è superiore al tasso di risparmio ( 3.3% ).
Guadagni vs Mercato: Si prevede che gli utili di ELK ( 52.6% all'anno) cresceranno più rapidamente del mercato Norwegian ( 9.7% all'anno).
Guadagni ad alta crescita: Si prevede che gli utili di ELK cresceranno in modo significativo nei prossimi 3 anni.
Ricavi vs Mercato: Si prevede che il fatturato di ELK ( 7.2% all'anno) crescerà più rapidamente del mercato Norwegian ( 2% all'anno).
Ricavi ad alta crescita: Si prevede che il fatturato di ELK ( 7.2% all'anno) crescerà più lentamente di 20% all'anno.
Previsioni di crescita dell'utile per azione
Rendimento futuro del capitale proprio
ROE futuro: Si prevede che il Return on Equity di ELK sarà basso tra 3 anni ( 9.7 %).
Scoprire le aziende in crescita
Analisi aziendale e situazione dei dati finanziari
| Dati | Ultimo aggiornamento (ora UTC) |
|---|---|
| Analisi dell'azienda | 2026/05/20 07:50 |
| Prezzo dell'azione a fine giornata | 2026/05/20 00:00 |
| Utili | 2026/03/31 |
| Utili annuali | 2025/12/31 |
Fonti dei dati
I dati utilizzati nella nostra analisi aziendale provengono da S&P Global Market Intelligence LLC. I seguenti dati sono utilizzati nel nostro modello di analisi per generare questo report. I dati sono normalizzati, il che può comportare un ritardo nella disponibilità della fonte.
| Pacchetto | Dati | Tempistica | Esempio Fonte USA * |
|---|---|---|---|
| Dati finanziari della società | 10 anni |
| |
| Stime di consenso degli analisti | +3 anni |
|
|
| Prezzi di mercato | 30 anni |
| |
| Proprietà | 10 anni |
| |
| Gestione | 10 anni |
| |
| Sviluppi principali | 10 anni |
|
* Esempio per i titoli statunitensi, per i titoli non statunitensi si utilizzano forme e fonti normative equivalenti.
Se non specificato, tutti i dati finanziari si basano su un periodo annuale ma vengono aggiornati trimestralmente. Si tratta dei cosiddetti dati TTM (Trailing Twelve Month) o LTM (Last Twelve Month). Per saperne di più.
Modello di analisi e Snowflake
I dettagli del modello di analisi utilizzato per generare questo report sono disponibili sulla nostra pagina Github; abbiamo anche guide su come utilizzare i nostri report e tutorial su Youtube.
Scoprite il team di livello mondiale che ha progettato e realizzato il modello di analisi Simply Wall St.
Metriche di settore e industriali
Le nostre metriche di settore e di sezione sono calcolate ogni 6 ore da Simply Wall St; i dettagli del nostro processo sono disponibili su Github.
Fonti analitiche
Elkem ASA è coperta da 9 analisti. 4 di questi analisti ha fornito le stime di fatturato o di utile utilizzate come input per il nostro report. Le stime degli analisti vengono aggiornate nel corso della giornata.
| Analista | Istituzione |
|---|---|
| null null | ABG Sundal Collier |
| Sebastian Satz | Citigroup Inc |
| Elliott Geoffrey Jones | Danske Bank |